Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.177
https://www.valueinhealthjournal.com/article/S1098-3015(13)02082-2/fulltext
Title :
Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02082-2&doi=10.1016/j.jval.2013.08.177
First page :
A352
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
163